Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Amato

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
Sexually Transmitted Infections|June 26, 2019
Substantial underdiagnosis of lymphogranuloma venereum in men who have sex with men in Europe: preliminary findings from a multicentre surveillance pilotMichelle Jayne Cole, Nigel Field, Rachel Pitt, et al.
British Journal of Cancer|June 27, 2002
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumoursK Fizazi, D M Prow, K-A Do, et al.
American Journal of Hematology|May 14, 2016
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher diseaseAri Zimran, Gloria Durán, Atul Mehta, et al.
The Journal of Urology|September 28, 2002
The role of caveolin-1 in androgen insensitive prostate cancerVladimir Mouraviev, Likun Li, Salahaldin A Tahir, et al.
Frontiers in Immunology|November 25, 2022
Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in miceDario Garcia-Dominguez, Carole Henry, LingZhi Ma, et al.
ACS Chemical Neuroscience|May 21, 2013
Substituted 1-Phenyl-3-(pyridin-2-yl)urea negative allosteric modulators of mGlu5: discovery of a new tool compound VU0463841 with activity in rat models of cocaine addictionRussell J Amato, Andrew S Felts, Alice L Rodriguez, et al.
Frontiers in Public Health|June 14, 2021
Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016-2019)Ida Sperle, Stine Nielsen, Viviane Bremer, et al.
Amino Acids|March 22, 2023
Amnio acid substitution at position 298 of human glucose-6 phosphatase-α significantly impacts its stability in mammalian cellsJingsong Cao, Arianna Markel, Erin Hanahoe, et al.
European Journal of Public Health|October 27, 2015
Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national surveyIngrid V van den Broek, Otilia Sfetcu, Marianne A van der Sande, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Lancet (London, England)|February 24, 2001
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trialS M Tu, R E Millikan, B Mengistu, et al.
Sexually Transmitted Infections|June 26, 2019
Substantial underdiagnosis of lymphogranuloma venereum in men who have sex with men in Europe: preliminary findings from a multicentre surveillance pilotMichelle Jayne Cole, Nigel Field, Rachel Pitt, et al.
British Journal of Cancer|June 27, 2002
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumoursK Fizazi, D M Prow, K-A Do, et al.
American Journal of Hematology|May 14, 2016
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher diseaseAri Zimran, Gloria Durán, Atul Mehta, et al.
The Journal of Urology|September 28, 2002
The role of caveolin-1 in androgen insensitive prostate cancerVladimir Mouraviev, Likun Li, Salahaldin A Tahir, et al.
Frontiers in Immunology|November 25, 2022
Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in miceDario Garcia-Dominguez, Carole Henry, LingZhi Ma, et al.
ACS Chemical Neuroscience|May 21, 2013
Substituted 1-Phenyl-3-(pyridin-2-yl)urea negative allosteric modulators of mGlu5: discovery of a new tool compound VU0463841 with activity in rat models of cocaine addictionRussell J Amato, Andrew S Felts, Alice L Rodriguez, et al.
Frontiers in Public Health|June 14, 2021
Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016-2019)Ida Sperle, Stine Nielsen, Viviane Bremer, et al.
Amino Acids|March 22, 2023
Amnio acid substitution at position 298 of human glucose-6 phosphatase-α significantly impacts its stability in mammalian cellsJingsong Cao, Arianna Markel, Erin Hanahoe, et al.
European Journal of Public Health|October 27, 2015
Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national surveyIngrid V van den Broek, Otilia Sfetcu, Marianne A van der Sande, et al.
Pageof 24